| Manufacturer ▼ | Drug Name | Indication | Stage | Status | Route of Administration | Drug Class |
|---|---|---|---|---|---|---|
| Praxis Precision Medicines Inc. | PRAX-562 | Rare Adult Cephalgias | Phase 2 | Oral | Neurology | |
| Praxis Precision Medicines Inc. | PRAX-114 | Essential Tremor | Phase 2 | oral | Neurology | |
| Praxis Precision Medicines Inc. | PRAX-114 | PTSD | Phase 2 | oral | Psychiatric | |
| Praxis Precision Medicines Inc. | PRAX-114 - (Acapella) | Major depressive disorder | Phase 2 | Oral | Psychiatric | |
| Praxis Precision Medicines Inc. | Vormatrigine (PRAX-628) - (POWER2) | Epilepsy | Phase 2 | Data Released | Oral | Neurology |
| Praxis Precision Medicines Inc. | PRAX-628 | Photo-Paroxysmal Response (PPR) | Phase 2 | Data Released | Oral | Neurology |
| Praxis Precision Medicines Inc. | PRAX-114 | Major Depressive Disorder and perimenopausal depression | Phase 2a | oral | Psychiatric | |
| Precigen Inc. | PRGN-2009 in combination with pembrolizumab | Recurrent/metastatic cervical cancer | Phase 2 | Clinical Pause | Intravenous | Oncology |